Volume 10, Number 8—August 2004
Dispatch
Syphilis in the HIV Era
Sigall Kassutto*
and John P. Doweiko*
and John P. Doweiko*
Table
Selected laboratory results 1 month after therapy for neurosyphilis in HIV-positive patient with neurosyphilisa
| Laboratory test | Result |
|---|---|
| Complete blood count | |
| Leukocytes | 5,700/μL |
| Hematocrit | 36% |
| Platelets | 295,000/μL |
| Electrolytes and renal function tests | Within normal limits |
| Liver function tests | Within normal limits |
| Cerebrospinal fluid evaluation | |
| Leukocytes | 8 cells/μL |
| Differential | 100% lymphocytes |
| Erythrocytes | 9 cells/μL |
| Protein | 33 mg/dL |
| Glucose | 78 mg/dL |
| CSF-VDRL | negative |
| HIV-1 testing | |
| ELISA + WB | positive |
| CD4 count | 899 cells/μL |
| Viral load (RT-PCR) | 878 copies/mL |
| Rapid plasma reagin testing | |
| Baseline | 1:128 |
| 1 month posttreatment | 1:32 |
| 3 months posttreatment | Nonreactive |
aCSF-VDRL, cerebrospinal fluid venereal disease research laboratory test; ELISA, enzyme-linked immunosorbent assay; WB, Western blot; RT-PCR, reverse transcription–polymerase chain reaction.
Page created: March 02, 2011
Page updated: March 02, 2011
Page reviewed: March 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.